Amicus Therapeutics Inc. buy Needham & Company LLC
Start price
18.09.25
/
50%
€7.20
Target price
18.09.26
€11.85
Performance (%)
71.81%
Price
27.04.26
€12.34
Summary
This prediction is currently active. With a performance of 71.81% the BUY prediction by Needham___Company_LL is a big success. This prediction currently runs until 18.09.26. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amicus Therapeutics Inc. | - | - |
| iShares Core DAX® | 2.591% | 2.467% |
| iShares Nasdaq 100 | -0.915% | -6.458% |
| iShares Nikkei 225® | 0.145% | -8.773% |
| iShares S&P 500 | -0.367% | -1.220% |
Comments by Needham___Company_LL for this prediction
In the thread Amicus Therapeutics Inc. diskutieren
Amicus Therapeutics (NASDAQ:FOLD) was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating. They now have a $14.00 price target on the stock.
Ratings data for FOLD provided by MarketBeat